BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3531847)

  • 1. Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.
    Hira SK; Abraham MS; Mwinga A; Kamanga J; Schmidt C
    Mykosen; 1986 Aug; 29(8):378-81. PubMed ID: 3531847
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of naftifine (Exoderil) cream in the treatment of dermatophytosis.
    Lee CT; Giam YC; Tan T
    Singapore Med J; 1987 Oct; 28(5):429-31. PubMed ID: 3324355
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F; Gartmann H; Weidinger G
    Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D; Reichenberger M
    Mykosen; 1980 Dec; 23(12):657-68. PubMed ID: 7012610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of a new antimycotic preparation (tolcyclate) in the treatment of pityriasis versicolor].
    Martín López J
    Actas Dermosifiliogr; 1980; 71(9-10):373-80. PubMed ID: 7013428
    [No Abstract]   [Full Text] [Related]  

  • 6. [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole].
    Haas PJ; Tronnier H; Weidinger G
    Mykosen; 1985 Jan; 28(1):33-40. PubMed ID: 3883160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
    G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.
    Gold MH; Bridges T; Avakian E; Plaum S; Pappert EJ; Fleischer AB; Hardas B
    Skinmed; 2011; 9(5):283-6. PubMed ID: 22165042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U; Stutz A; Petranyi G; Stephen A
    Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H; Luszpinski P
    Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group.
    J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration].
    Meinicke K; Striegel C; Weidinger G
    Mykosen; 1984 Dec; 27(12):608-14. PubMed ID: 6395017
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of therapeutic effectiveness with tolciclate and miconazole in superficial dermatophytosis and in pityriasis versicolor (author's transl)].
    Wiedey K; Renovanz HD; Maier-Lenz H
    Mykosen; 1982 Mar; 25(3):126-32. PubMed ID: 7045655
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study with Hoe 296 in glabrous skin dermatophytosis and pityriasis versicolor].
    González-Ochoa A; Sarmiento-Cristóbal J; Ortega-Llamas O
    Rev Invest Salud Publica; 1974; 34(4):175-81. PubMed ID: 4617272
    [No Abstract]   [Full Text] [Related]  

  • 15. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis.
    Millikan LE; Galen WK; Gewirtzman GB; Horwitz SN; Landow RK; Nesbitt LT; Roth HL; Sefton J; Day RM
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):52-6. PubMed ID: 3279083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis.
    Jordon RE; Rapini RP; Rex IH; Katz HI; Hickman JG; Bard JW; Medansky RS; Lew-Kaya DA; Sefton J; DeGryse RE
    Int J Dermatol; 1990; 29(6):441-2. PubMed ID: 2397973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Naftifin in severe dermatomycosis--controlled comparison of efficacy with econazole].
    Nolting S; Weidinger G
    Mykosen; 1985 Feb; 28(2):69-76. PubMed ID: 3885027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contact allergy to the antifungal agent naftifin].
    Hoting E; Küchmeister B; Hausen BM
    Derm Beruf Umwelt; 1987; 35(4):124-7. PubMed ID: 2959458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole].
    Bojanovsky A; Haas P
    Fortschr Med; 1985 Jul; 103(25):677-9. PubMed ID: 3897005
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis versicolor resembling pityriasis rotunda.
    Ena P; Siddi GM
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):85-7. PubMed ID: 11952303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.